Recent content by mtb4u

Here's a pharmaceutical company with no approved pipeline, just drugs in clinical trials. The stock is wacky, though, and has very little predictability. I've been keeping an eye on it lately because of MEM 1003 and MEM 3454. Volume has been very high during today's after hours, and ask...

props to stoney, one of the most profitable and dead-on one-sided conversations I've ever had the chance to read.

Not tomorrow...Mid-Late Feb.

Does anybody have an opinion on the 8-k filed by SUNW earlier denoting a $700 million transaction from KKR holdings to SUNW? To me it looks like classic KKR...buy low and restructure, but the whole thing seems pretty sketch...maybe Sun is getting into the drug trafficking business. Long on...

:D

Haha. I agree with you on the price of Myogen; however, ambrisentan did pass phase II, where most drugs fail, and to my knowledge the FDA hasn't placed any clinical holds due to bunk data. All I mean to say is, if anybody can shove a drug from trials to pharmacy it's Gilead...nobody, including...

Ah, duh!-Thanks, sir. I see it now...in the recent news section. I apologize, I'm usually more careful than this. Cheers!

I've been watching this stock for some time now (years)... hasn't been very interesting lately, and has shown signs of going into a downtrend. It's up 10% so far today...hasn't been down yet. I really don't understand this. Is it interest rates? They don't have any new meds out, the peak of...

It's hard to know over the internet, but I'm a pretty austere and hard-working guy...I don't drop attitude unless it's needed, and when somebody is explaining, I shut my mouth and listen. I assure you that any attitude you sensed was poorly communicated respect. In fact, I've set a note to...

boiler room, huh? thank you for your explanation.

I recently received a SPAM message demanding me to invest in Human Biosystems, a stock valued at $.12 on the day of the e-mail. Somehow, I avoided the urge to turn all of my cash into HSBC :p , but I experienced a surge of interest in the idea of "penny stocks". In fact, I've long been...